Imago BioSciences, Inc.
IMGODelisted Jan 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623715
Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Imago BioSciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 106 | 1 | 0 | −105 |
| Shares | 29.3M | 19.3K | 0 | −29.3M (−100.0%) |
| Value | $1.05B | $694.0K | $0 | −$1.05B (−100.0%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Imago BioSciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (105)
Institutions that held Imago BioSciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Showing the largest 100 of 105 by value.
Not filed for Q1 2023 yet (1)
Institutions that held Imago BioSciences, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 19,291 | $694.0K |